Novel oral anticoagulant use in adult Fontan patients: a single center experience. Congenit Heart Dis. 2018;13:541 547. doi: 583. Yang H, Bouma BJ, Mulder BJM; Non vitamin K antagonist Oral anti- coagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) Investigators. Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease? Cardiovasc Drugs Ther. 584. Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, Hsia T-Y, Hsu DT, Kovacs AH, McCrindle BW, et al; on behalf of the American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing. Evaluation and manage- ment of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation. 2019;140:e234 e284. 585. Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. 585a. International Society for Adult Congenital Heart Disease. NOTE Registry. Accessed December 1, 2019. http://www.isachd.org/content/note-registry 586. Elbardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, Schaff HV. Embolic potential of cardiac tumors and outcome af- ter resection: a case-control study. Stroke. 2009;40:156 162. doi: 587. Grinda JM, Couetil JP, Chauvaud S, D Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A. Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg. 588. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart 589. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 590. Lai MM, Li TC, Lin CL, Sung FC, Lin CC, Liu CS, Kao CH. Benign neoplasm of the heart increases the risk of first ischemic stroke: a population-based cohort study. 